Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Microwave scanner could spot breast cancer without radiation

NCT ID NCT05757427

Diagnosis Sponsor: MVG Industries SAS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new microwave imaging device called Wavelia #2 to see if it can detect and measure breast cancers and benign lumps. 73 women with breast abnormalities larger than 1 cm were scanned. The goal was to see how well the device finds lesions and tells cancerous from non-cancerous ones, using safe, non-ionizing radiation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wavelia #2 microwave breast imaging device
What this could lead to
If successful, this could provide a safe, radiation-free screening tool for breast cancer detection.
What could go wrong
This is a small pilot study with only 73 participants, so results may not apply to the general population. The device is still experimental and not yet proven for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

73 people

The number who actually took part.

Started

Mar 2023

Finished

Oct 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed Consent * Female subjects with an investigator assessed discrete breast abnormality of size \> 1cm * Able and willing to comply with the requirements of this study protocol * Negative urine pregnancy test on the day of microwave imaging procedure (if of childbearing potential) * intact breast skin (i.e., without bleeding lesion, no evidence of inflammation and/or erythema of the breast) * Able to comfortably lie reasonably still in a prone position for approximately 15 minutes * Have had biopsy more than 2 weeks prior to the microwave breast investigation (if applicable) Exclusion Criteria: * Have a cup size of A or whose breast is deemed too small to allow MBI assessment in the opinion of the investigator * Are pregnant or breast-feeding * Have had surgery on either breast within the past 12 months * Have any active or metallic implant other than a biopsy clip * Would be unsuitable for an MBI scan or unlikely to follow the protocol in the opinion of the Investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign breast lesion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast benign neoplasm breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Galway University Hospital/Symptomatic Breast Unit

    Galway, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.